Viability of causative pathogen in patients with drug-sensitive and drug-resistant forms of respiratory tuberculosis

Viability of causative pathogen in patients with drug-sensitive and drug-resistant forms of respiratory tuberculosis

To predict outcomes of tuberculosis we investigated the viability of Mycobacterium tuberculosis (MTB) in relation to drug resistance of strains and clinical manifestations of tuberculosis. During the study on solid Löwenstein - Jensen medium, we determined the speed, growth rate and drug resistance...

Full description

Bibliographic Details
Main Authors:	E. Yu. Zorkaltseva, O. A. Vorobyeva, E. D. Savilov, S. N. Shugaeva, V. A. Astafyev
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2017-09-01
Series:	Acta Biomedica Scientifica
Subjects:	tuberculosis the viability of mycobacterium tuberculosis drug resistance hiv-infection
Online Access:	https://www.actabiomedica.ru/jour/article/view/437

Similar Items

Viability, biofilm formation, and MazEF expression in drug-sensitive and drug-resistant Mycobacterium tuberculosis strains circulating in Xinjiang, China
by: Zhao JL, et al.
Published: (2018-03-01)

DRUG RESISTANCE, VIABILITY AND VIRULENCE IN VITRO ОF MYCOBACTERIUM TUBERCULOSIS STRAINS OF DIFFERENT GENOTYPES
by: O. A. Manicheva, et al.
Published: (2014-07-01)

TYPICAL FEATURES OF PRIMARY DRUG RESISTANCE AND VIABILITY OF MYCOBACTERIA IN TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION
by: N. M. Koretskaya, et al.
Published: (2017-02-01)

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

Tuberculosis en Colombia: análisis de la situación epidemiológica, año 2006 Epidemiologic situation of tuberculosis in Colombia, 2006
by: César Augusto Castiblanco, et al.
Published: (2008-09-01)

EFFECT OF SOME MEDICINAL PLANTS ON GROWTH OF MYCOBACTERIUM TUBERCULOSIS, MULTI DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM OTHER THAN TUBERCULOSIS
by: Prashant Shukla, et al.
Published: (2013-12-01)

Multi-Drug Resistance of Mycobacterium Tuberculosis – the Problem of Modern Phthisiology
by: E. Yu. Zorkaltseva, et al.
Published: (2019-05-01)

Criteria for the integration of epidemic processes of HIV infection and tuberculosis
by: S. N. Shugaeva, et al.
Published: (2019-05-01)

Risk factors of developing tuberculosis in children with perinatal HIV infection
by: S. N. Shugaeva, et al.
Published: (2016-02-01)

Drug resistance pattern of Mycobacterium tuberculosis in the province with highest incidence of tuberculosis in Iran
by: N Mansoori, et al.
Published: (2016-01-01)

Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli
by: Angelo Iacobino, et al.
Published: (2017-01-01)

Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment
by: Priscila C. B. Halicki, et al.
Published: (2018-04-01)

Investigation of the activity of sulfonamide anti-bacterial drugs in Mycobacterium tuberculosis and the role of oxidative stress on the efficacy of these drugs
by: Macingwana, Lubabalo
Published: (2014)

Evaluation of Sensitivity and Resistance of Linezolid in Pre Extensively Drug Resistance Tuberculosis and Extensively Drug Resistance Tuberculosis at a Tertiary Care Hospital, Jamnagar, Gujarat, India
by: Dipali Maganbhai Gavali, et al.
Published: (2019-11-01)

Medical and social characteristics of children with tuberculosis in conditions of social insufficiency in the Irkutsk region
by: E. Y. Zorkaltseva, et al.
Published: (2017-09-01)

Previous use of quinolones: a surrogate marker for first line anti-tuberculosis drugs resistance in HIV-infected patients?
by: Caroline Deutschendorf, et al.

Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals
by: Catherine Riou, et al.
Published: (2017-08-01)

Contribution to the research on drug resistant Mycobacterium tuberculosis
by: Stoffels, Karolien
Published: (2014)

Disseminated tuberculosis with prostatic abscesses in an immunocompromised patient—A case report and review of literature
by: Upasana Joneja, et al.
Published: (2016-01-01)

Natural Compounds from Mexican Medicinal Plants as Potential Drug Leads for Anti-Tuberculosis Drugs
by: ROCIO GÓMEZ-CANSINO, et al.

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)
by: I. A. Burmistrova, et al.
Published: (2020-02-01)

EPIDEMIOLOGICAL STUDY OF MAIN CLONES DISTRIBUTION GENOTYPE BEIJING OF MYCOBACTERIUM TUBERCULOSIS WITHIN IRKUTSK REGION
by: S. N. Zhdanova, et al.
Published: (2017-12-01)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
by: Vinayak Singh, et al.
Published: (2021-09-01)

Comparative molecular study of Mycobacterium tuberculosis strains, in times of antimicrobial drug resistance
by: G. Varela, et al.
Published: (2005-03-01)

Mutations in Mycobacterium tuberculosis Isolates with Discordant Results for Drug-Susceptibility Testing in Peru
by: Solari, L., et al.
Published: (2020)

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi
by: Annie Zhang, et al.
Published: (2018-06-01)

Extensively drug-resistant tuberculosis: a case report and literature review
by: João Alves de Araújo-Filho, et al.

Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan
by: Yassir A. Shuaib, et al.
Published: (2020-03-01)

Possible Transmission Mechanisms of Mixed Mycobacterium tuberculosis Infection in High HIV Prevalence Country, Botswana
by: Yeonsoo Baik, et al.
Published: (2020-05-01)

THE GROWTH RATE PHENOTYPIC PROPERTY OF MYCOBACTERIUM TUBERCULOSIS CLINICAL STRAINS: DEPENDENCE ON TUBERCULOSIS LOCALIZATION, TREATMENT, DRUG SUSCEPTIBILITY
by: O. A. Manicheva, et al.
Published: (2018-09-01)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
by: Manuela Pardini, et al.
Published: (2005-03-01)

Immunological markers of protective immune reconstitution in HIV infected persons sensitised by Mycobacterium tuberculosis
by: Jhilmeet, Nishtha
Published: (2018)

TUBERCULOSIS IN CHILDREN
by: Susanna Esposito
Published: (2013-11-01)

Genome-wide analysis of Mycobacterium tuberculosis polymorphisms reveals lineage-specific associations with drug resistance
by: Yaa E. A. Oppong, et al.
Published: (2019-03-01)

Novel drug delivery systems: Desired feat for tuberculosis
by: Kirtipal Kaur, et al.
Published: (2010-01-01)

NOVEL DRUG DELIVERY SYSTEMS: DESIRED FEAT FOR TUBERCULOSIS
by: Kirtipal Kaur, et al.
Published: (2010-06-01)

Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran
by: Mansoori N, et al.
Published: (2020-07-01)

Comparison of Chest X-Ray Assessment in Multi-Drug Resistance to Drug- Sensitive Tuberculosis Patients
by: Sari Afiah Miyuki Rifani, et al.
Published: (2020-12-01)